Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface

Colloids and Surfaces B: Biointerfaces

Volumn 100, Issue , 2012, Pages 9-15

  Kuo, Yung Chih ^a   Wang, Cheng Ting ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Heparin; Induced pluripotent stem cell; Neuron; Poly( hydroxybutyrate); Poly(e open caprolactone); Scaffold

Indexed keywords

CAPROLACTONE; FLUORESCENT INTENSITY; GEL CONCENTRATION; HEPARIN; HYDROXYBUTYRATE; IMMUNOCHEMICAL STAINING; NERVE TISSUE ENGINEERING; NEURONAL DIFFERENTIATION; PLURIPOTENT; PLURIPOTENT STEM CELLS; WEIGHT PERCENTAGES;

BIOLOGICAL MATERIALS; CYTOLOGY; GRAFTING (CHEMICAL); NEURONS; POLYSACCHARIDES; SCAFFOLDS; STEM CELLS; SULFUR;

SCAFFOLDS (BIOLOGY);

BETA TUBULIN; CARBON; HEPARIN; HYBRID POLYESTER SCAFFOLD; NITROGEN; OXYGEN; POLY(3 HYDROXYBUTYRIC ACID); POLYCAPROLACTONE; POLYESTER; STAGE SPECIFIC EMBRYO ANTIGEN 1; SULFUR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; GEL; IMMUNOHISTOCHEMISTRY; MOLECULAR WEIGHT; NERVE CELL DIFFERENTIATION; PLURIPOTENT STEM CELL; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE PROPERTY;

ANIMALS; ANTIGENS, CD15; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; GELS; GENE EXPRESSION; HEPARIN; HYDROXYBUTYRATES; INDUCED PLURIPOTENT STEM CELLS; MICE; MICROSCOPY, ELECTRON, SCANNING; NERVE TISSUE; NEURONS; PHOTOELECTRON SPECTROSCOPY; POLYESTERS; POROSITY; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TUBULIN;

IPS;

EID: 84862775484     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.05.014     Document Type: Article

References (20)

1. Coulembier O., Degee P., Hedrick J.L., Dubois P. From controlled ring-opening polymerization to biodegradable aliphatic polyester: especially poly(beta-malic acid) derivatives. Prog. Polym. Sci. 2006, 31:723-747.
2. Woodward S.C., Brewer P.S., Moatamed F., Schindler A., Pitt C.G. The intracellular degradation of poly(e{open}-caprolactone). J. Biomed. Mater. Res. 1985, 19:437-444.
3. Nisbet D.R., Yu L.M.Y., Zahir T., Forsythe J.S., Shoichet M.S. Characterization of neural stem cells on electrospun poly(epsilon-caprolactone) submicron scaffolds: evaluating their potential in neural tissue engineering. J. Biomater. Sci. Polym. Ed. 2008, 19:623-634.
4. Young R.C., Wiberg M., Terenghi G. Poly-3-hydroxybutyrate (PHB): a resorbable conduit for long-gap repair in peripheral nerves. Br. J. Plast. Surg. 2002, 55:235-240.
5. Cushing M.C., Liao J.T., Anseth K.S. Activation of valvular interstitial cells is mediated by transforming growth factor-beta 1 interactions with matrix molecules. Matrix Biol. 2005, 24:428-437.
6. Pufe T., Groth G., Goldring M.B., Tillmann B., Mentlein R. Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes. Osteoarthritis Cartilage 2007, 15:155-162.
7. Freeman I., Kedem A., Cohen S. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 2008, 29:3260-3268.
8. Rajangam K., Arnold M.S., Rocco M.A., Stupp S.I. Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity. Biomaterials 2008, 29:3298-3305.
9. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
10. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
11. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
12. Aoi T., Yae K., Nakagawa M., Ichisaka T., Okita K., Takahashi K., Chiba T., Yamanaka S. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008, 321:699-702.
13. Salewski R.P.F., Eftekharpour E., Fehlings M.G. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?. J. Cell. Physiol. 2010, 222:515-521.
14. Kuo Y.C., Tsai Y.T. Inverted colloidal crystal scaffolds for uniform cartilage regeneration. Biomacromolecules 2010, 11:731-739.
15. Li J.L., Pan J.L., Zhang L.G., Yu Y.T. Culture of hepatocytes on fructose-modified chitosan scaffolds. Biomaterials 2003, 24:2317-2322.
16. Hou Q.P., Grijpma D.W., Feijen J. Porous polymeric structures for tissue engineering prepared by a coagulation, compression moulding and salt leaching technique. Biomaterials 2003, 24:1937-1947.
17. Mao J.S., Zhao L.G., Yin Y.J., Yao K.D. Structure and properties of bilayer chitosan-gelatin scaffolds. Biomaterials 2003, 24:1067-1074.
18. Stadtfeld M., Brennand K., Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr. Biol. 2008, 18:890-894.
19. Silva J., Barrandon O., Nichols J., Kawaguchi J., Theunissen T.W., Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008, 6:2237-2247.
20. Tsuji O., Miura K., Okada Y., Fujiyoshi K., Mukaino M., Nagoshi N., Kitamura K., Kumagai G., Nishino M., Tomisato S., Higashi H., Nagai T., Katoh H., Kohda K., Matsuzaki Y., Yuzaki M., Ikeda E., Toyama Y., Nakamura M., Yamanaka S., Okano H. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12704-12709.